What You Need to Know Ahead of Eli Lilly Earnings

Analyst Estimates for Q2 2024Q1 2024Q2 2023Revenue$9.97 billion$8.77 billion$8.31 billionDiluted EPS$2.65$2.48$1.95Net Income$2.39 billion$2.24 billion$1.76 billion Key Metric: Mounjaro, Zepbound Sales Demand for the weight-loss drugs has boosted the revenue and shares of Eli Lilly along with Ozempic and Wegovy-maker Novo Nordisk (NVO) over the past year, as the companies have increased production capacity to meet demand. In its first-quarter report, Eli Lilly lifted its revenue and profit projections fo ...